Oncolytics Biotech Files 6-K
Ticker: ONCY · Form: 6-K · Filed: Dec 18, 2024 · CIK: 1129928
Sentiment: neutral
Topics: reporting, foreign-private-issuer, sec-filing
Related Tickers: ONCY
TL;DR
ONCOLYTICS BIOTECH (ONCY) files 6-K, confirms foreign private issuer status, filing 20-F.
AI Summary
Oncolytics Biotech Inc. filed a Form 6-K on December 18, 2024, reporting as a foreign private issuer for the month of December 2024. The company is based in Calgary, Alberta, Canada, and operates in the Pharmaceutical Preparations industry. This filing indicates they will file annual reports under Form 20-F.
Why It Matters
This filing confirms Oncolytics Biotech Inc.'s status as a foreign private issuer and its reporting obligations with the SEC, providing transparency for investors.
Risk Assessment
Risk Level: low — This is a routine administrative filing confirming reporting status and not indicating any new material events or financial changes.
Key Players & Entities
- ONCOLYTICS BIOTECH INC (company) — Registrant
- 20241218 (date) — Filing Date
- December 2024 (date) — Reporting Period
- Calgary, Alberta, Canada (location) — Company Headquarters
- 2834 (industry_code) — Standard Industrial Classification
- 001-38512 (sec_file_number) — SEC File Number
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, for the month of December 2024.
Which form will Oncolytics Biotech Inc. use for its annual reports?
Oncolytics Biotech Inc. will file its annual reports under cover of Form 20-F.
Where is Oncolytics Biotech Inc. located?
Oncolytics Biotech Inc. is located at Suite 804, 322 11th Avenue SW, Calgary, Alberta, Canada T2R 0C5.
What is the Standard Industrial Classification code for Oncolytics Biotech Inc.?
The Standard Industrial Classification code for Oncolytics Biotech Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What is the Commission File Number for this filing?
The Commission File Number for this filing is 001-38512.
Filing Stats: 334 words · 1 min read · ~1 pages · Grade level 17.1 · Accepted 2024-12-18 14:22:54
Filing Documents
- form6kascogiabstracttitles.htm (6-K) — 18KB
- oncyascogiabstracttitles.htm (EX-99.1) — 17KB
- 0001129928-24-000075.txt ( ) — 36KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Oncolytics Biotech Inc. (Registrant) By s Kirk Look Date December 18, 2024 Kirk Look Chief Financial Officer